Technical Analysis for GDR - Genedrive Plc

Grade Last Price % Change Price Change
F 71.0 0.00% 0.00
GDR closed unchanged on Tuesday, April 13, 2021, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical GDR trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Inside Day Range Contraction 0.00%
Older End-of-Day Signals for GDR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
2x Volume Pace about 21 hours ago
1.5x Volume Pace about 21 hours ago
Non-ADX 1,2,3,4 Bearish Retracement Entry about 21 hours ago
1,2,3, Bearish Retracement Entry about 21 hours ago
Fell Below Previous Day's Low about 21 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Genedrive Plc Description

Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Its Preclinical Research Services segment provides pre-clinical testing services. Its Pharmacogenomic Services segment specializes in molecular measures of biological effect. Its Diagnostics segment is commercializing the Genedrive molecular testing platform. Its Preclinical Research Services activities relate to the testing of drugs for drug development companies. The Preclinical Research Services division has developed a range of models across therapeutic pathways, including oncology, gastrointestinal disease, skin care and wound healing. The Pharmacogenomics Service offers multi system transcriptional profiling and laser capture microscopy.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Gas Research Biotechnology Clinic Disease Life Sciences Testing Skin Oncology Drugs Laser Skin Care E Testing Drug Development Omics Clinical Research Health Sciences Molecular Pharmacology Microscopy Clinical Research Services Medical Genetics Profiling Genomics Genomics Services Molecular Diagnostics Pre Clinical Development

Is GDR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 302.6013
52 Week Low 38.0
Average Volume 1,434,124
200-Day Moving Average 89.87
50-Day Moving Average 112.49
20-Day Moving Average 95.73
10-Day Moving Average 72.65
Average True Range 12.76
ADX 31.33
+DI 19.19
-DI 30.56
Chandelier Exit (Long, 3 ATRs ) 116.71
Chandelier Exit (Short, 3 ATRs ) 98.29
Upper Bollinger Band 152.38
Lower Bollinger Band 39.07
Percent B (%b) 0.28
BandWidth 118.37
MACD Line -13.05
MACD Signal Line -10.86
MACD Histogram -2.1852
Fundamentals Value
Market Cap 40.09 Million
Num Shares 56.5 Million
EPS -14.00
Price-to-Earnings (P/E) Ratio -5.07
Price-to-Sales 18.97
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 80.15
Resistance 3 (R3) 79.77 76.33 78.63
Resistance 2 (R2) 76.33 74.00 76.53 78.12
Resistance 1 (R1) 73.67 72.56 75.00 74.05 77.61
Pivot Point 70.23 70.23 70.90 70.43 70.23
Support 1 (S1) 67.57 67.90 68.90 67.95 64.39
Support 2 (S2) 64.13 66.46 64.33 63.88
Support 3 (S3) 61.47 64.13 63.38
Support 4 (S4) 61.85